Literature DB >> 20601455

Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion.

Pavel I Zimin1, Bojan Garic, Silke B Bodendiek, Cédrick Mahieux, Heike Wulff, Boris S Zhorov.   

Abstract

Voltage-gated potassium channels (Kv) are targets for drugs of large chemical diversity. Although hydrophobic cations block Kv channels with Hill coefficients of 1, uncharged electron-rich (cationophilic) molecules often display Hill coefficients of 2. The mechanism of the latter block is unknown. Using a combination of computational and experimental approaches, we mapped the receptor for the immunosuppressant PAP-1 (5-(4-phenoxybutoxy)psoralen), a high-affinity blocker of Kv1.3 channels in lymphocytes. Ligand-docking using Monte Carlo minimizations suggested a model in which two cationophilic PAP-1 molecules coordinate a K(+) ion in the pore with their coumarin moieties, whereas the hydrophobic phenoxyalkoxy side chains extend into the intrasubunit interfaces between helices S5 and S6. We tested the model by generating 58 point mutants involving residues in and around the predicted receptor and then determined their biophysical properties and sensitivity to PAP-1 by whole-cell patch-clamp. The model correctly predicted the key PAP-1-sensing residues in the outer helix, the P-loop, and the inner helix and explained the Hill coefficient of 2 by demonstrating that the Kv1.3 pore can accommodate two or even four PAP-1 molecules. The model further explained the voltage-dependence of block by PAP-1 and its thousand-fold selectivity for Kv1.3 over non-Kv1 channels. The 23- to 125-fold selectivity of PAP-1 for Kv1.3 over other Kv1 channels is probably due to its preferential affinity to the C-type inactivated state, in which cessation of K(+) flux stabilizes the tripartite PAP-1:K(+):PAP-1 complex in the pore. Our study provides a new concept for potassium channel block by cationophilic ligands.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601455      PMCID: PMC2981387          DOI: 10.1124/mol.110.064014

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  48 in total

1.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

2.  Atomic determinants of state-dependent block of sodium channels by charged local anesthetics and benzocaine.

Authors:  Denis B Tikhonov; Iva Bruhova; Boris S Zhorov
Journal:  FEBS Lett       Date:  2006-10-24       Impact factor: 4.124

Review 3.  Targeting effector memory T-cells with Kv1.3 blockers.

Authors:  Heike Wulff; Michael Pennington
Journal:  Curr Opin Drug Discov Devel       Date:  2007-07

Review 4.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

5.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Authors:  Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael W Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen Griffey; Hans-Guenther Knaus; Gerald T Nepom; George A Gutman; Peter A Calabresi; K George Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

6.  Mechanism of intracellular block of the KcsA K+ channel by tetrabutylammonium: insights from X-ray crystallography, electrophysiology and replica-exchange molecular dynamics simulations.

Authors:  José D Faraldo-Gómez; Esin Kutluay; Vishwanath Jogini; Yanxiang Zhao; Lise Heginbotham; Benoît Roux
Journal:  J Mol Biol       Date:  2006-09-29       Impact factor: 5.469

7.  Sodium channels: ionic model of slow inactivation and state-dependent drug binding.

Authors:  Denis B Tikhonov; Boris S Zhorov
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

Review 8.  hERG potassium channels and cardiac arrhythmia.

Authors:  Michael C Sanguinetti; Martin Tristani-Firouzi
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

9.  Monte Carlo-energy minimization of correolide in the Kv1.3 channel: possible role of potassium ion in ligand-receptor interactions.

Authors:  Iva Bruhova; Boris S Zhorov
Journal:  BMC Struct Biol       Date:  2007-01-29

10.  Modelling insecticide-binding sites in the voltage-gated sodium channel.

Authors:  Andrias O O'Reilly; Bhupinder P S Khambay; Martin S Williamson; Linda M Field; B A Wallace; T G Emyr Davies
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

View more
  9 in total

1.  Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the rat.

Authors:  B Hao; Z-W Chen; X-J Zhou; P I Zimin; G P Miljanich; H Wulff; Y-X Wang
Journal:  Xenobiotica       Date:  2010-11-11       Impact factor: 1.908

2.  Channels: Sticking to nooks and crannies.

Authors:  Heike Wulff; Vladimir Yarov-Yarovoy
Journal:  Nat Chem Biol       Date:  2013-08       Impact factor: 15.040

Review 3.  Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Authors:  Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič
Journal:  Med Res Rev       Date:  2021-05-01       Impact factor: 12.944

Review 4.  Mechanisms Underlying C-type Inactivation in Kv Channels: Lessons From Structures of Human Kv1.3 and Fly Shaker-IR Channels.

Authors:  Seow Theng Ong; Anu Tyagi; K George Chandy; Shashi Bhushan
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 5.  Predicting Structural Details of the Sodium Channel Pore Basing on Animal Toxin Studies.

Authors:  Denis B Tikhonov; Boris S Zhorov
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

6.  Side pockets provide the basis for a new mechanism of Kv channel-specific inhibition.

Authors:  Stefanie Marzian; Phillip J Stansfeld; Markus Rapedius; Susanne Rinné; Ehsan Nematian-Ardestani; Jennifer L Abbruzzese; Klaus Steinmeyer; Mark S P Sansom; Michael C Sanguinetti; Thomas Baukrowitz; Niels Decher
Journal:  Nat Chem Biol       Date:  2013-06-02       Impact factor: 16.174

7.  Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents.

Authors:  Andrea Mattarei; Matteo Romio; Antonella Managò; Mario Zoratti; Cristina Paradisi; Ildikò Szabò; Luigi Leanza; Lucia Biasutto
Journal:  Front Oncol       Date:  2018-04-23       Impact factor: 6.244

8.  Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family.

Authors:  Roberta Peruzzo; Andrea Mattarei; Michele Azzolini; Katrin Anne Becker-Flegler; Matteo Romio; Giovanni Rigoni; Andrea Carrer; Lucia Biasutto; Sofia Parrasia; Stephanie Kadow; Antonella Managò; Andrea Urbani; Andrea Rossa; Gianpietro Semenzato; Maria Eugenia Soriano; Livio Trentin; Syed Ahmad; Michael Edwards; Erich Gulbins; Cristina Paradisi; Mario Zoratti; Luigi Leanza; Ildikò Szabò
Journal:  Redox Biol       Date:  2020-09-06       Impact factor: 11.799

9.  Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α 2 β 3 γ 2 GABAA Receptor.

Authors:  Brandon Pressly; Ruth D Lee; Bogdan Barnych; Bruce D Hammock; Heike Wulff
Journal:  Mol Pharmacol       Date:  2020-10-27       Impact factor: 4.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.